Login / Signup

Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study.

Daniel FifeM Soledad CepedaAlan BasemanHenry RichardsPeter HuH Lynn StarrAnthony G Sena
Published in: PloS one (2018)
ClinicalTrials.gov NCT02730572.
Keyphrases
  • attention deficit hyperactivity disorder
  • adverse drug
  • healthcare
  • drug delivery
  • emergency department
  • electronic health record